Exploring the factors that affect blood cholesterol and heart disease risk: Is dietary cholesterol as bad for you as history leads us to believe?

Advances in Nutrition

Volumn 3, Issue 5, 2012, Pages 711-717

  Kanter, Mitchell M ^a   Kris Etherton, Penny M ^b   Fernandez, Maria Luz ^c   Vickers, Kasey C ^d   Katz, David L ^e  

^a Egg Nutrition Center   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHOLESTEROL INTAKE; DIET; EGG; HEALTH CARE POLICY; HEART DISEASE; HUMAN; RISK FACTOR;

CARDIOVASCULAR DISEASES; CHOLESTEROL, DIETARY; CHOLESTEROL, LDL; DIET; EGGS; HEART DISEASES; HUMANS; NUTRITION POLICY; RISK FACTORS;

EID: 84871980453     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.111.001321     Document Type: Conference Paper

References (52)

1. Fernandez ML, Calle MC. Revisiting dietary cholesterol recommendations: does the evidence support a 300 mg/d limit? Curr Atheroscler Rep. 2010;12:377-83.
2. Goodrow EF, Wilson TA, Houde SC, Vishwanathan R, Scollin PA, Handelman G, Nicolosi RJ. Consumption of one egg per day increases serum lutein and zeaxanthin concentrations in older adults without altering serum lipid and lipoprotein cholesterol concentrations. J Nutr. 2006;136:2519-24.
3. Ata S, Barona J, Kopec R, Jones J, Calle M, Schwartz S, Fernandez M. Consumption of one regular egg or a lutein-enriched egg per day increases HDL cholesterol, reduces apolipoprotein B and the number of small LDL particles while increasing plasma carotenoids and macular pigment density in adult subjects. FASEB J. 2010;24:A92.4
4. U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary guidelines for Americans 2010. 7th ed. Washington, DC: U.S. Government Printing Office, 2010.
5. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114:82-96.
6. Institute of Medicine. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids.Washington, DC: National Academies Press;2002.
7. Eaton SB. Evolutionary health promotion. Prev Med. 2002;34:109-18.
8. Eaton SB, Eaton III SB, Konner MJ. Paleolithic nutrition revisited: a twelve-year retrospective on its nature and implications. Eur J Clin Nutr. 1997;51:207-16.
9. Lev-Ran A. Human obesity: an evolutionary approach to understanding our bulging waistline. Diabetes Metab Res Rev. 2001;17:347-62.
10. Konner M, Eaton SB. Paleolithic nutrition: twenty-five years later. Nutr Clin Pract. 2010;25:594-602.
11. Harman NL, Leeds AR, Griffin BA. Increased dietary cholesterol does not increase plasma low density lipoprotein when accompanied by an energy-restricted diet and weight loss. Eur J Nutr. 2008;47:287-93.
12. Hu FB, Stampfer MJ, Rimm EB, Manson JE, Ascherio A, Colditz GA, Rosner BA, Spiegelman D, Speizer FE, Sacks FM, et al. A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA. 1999;281:1387-94.
13. Fernandez ML. Dietary cholesterol provided by eggs and plasma lipoproteins in healthy populations. Curr. OpinMed Nutr Met Care. 2006;9:8-12.
14. Ballesteros MN, Cabrera RM, Saucedo MS, Fernandez ML. Dietary cholesterol does not increase biomarkers for chronic disease in a pediatric population from northern Mexico. Am J Clin Nutr. 2004;80:855-61.
15. Herron KL, Lofgren IE, Sharma M, Volek JS, Fernandez ML. A high intake of dietary cholesterol does not result in more atherogenic LDL particles in men and women independent of response classification. Metabolism. 2004;53:823-30.
16. Greene CM, Zern TL, Wood R, Shrestha S, Aggarwal D, Sharman M, Volek JS, Fernandez ML. Maintenance of the LDL cholesterol: HDL cholesterol ratio in an elderly population given a dietary cholesterol challenge. J Nutr. 2005;135:2793-8.
17. Mutungi G, Ratliff J, Puglisi M, Torres-Gonzalez M, Vaishnav U, Leite JO, Quann E, Volek JS, Fernandez ML. Dietary cholesterol from eggs increases HDL cholesterol in overweight men consuming a carbohydrate restricted diet. J Nutr. 2008;138:272-6.
18. Mayurasakorn K, Srisura W, Sitphahul P, Hongto PO. High-density lipoprotein cholesterol changes after continuous egg consumption in healthy adults. J Med Assoc Thai. 2008;91:400-7.
19. Greene CM, Waters D, Clark RM, Contois JH, FernandezML. Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population. Nutr Metab (Lond). 2006;3:6.
20. Mutungi G, Waters D, Ratliff J, Puglisi M, Clark RM, Fernandez ML. Eggs distinctly modulate plasma carotenoids and lipoprotein subclasses in adult men following a carbohydrate-restricted diet. J Nutr Biochem. 2010;21:261-7.
21. Koba S, Hirano T, Ito Y, Tsunoda F, Yokota Y, Ban Y, Iso Y, Suzuki H, Katagiri T. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases. Atherosclerosis. 2006;1889:206-14.
22. Pascot A, Lemieux I, Prud'homme D, Tremblay A, Nadeau A, Couillard C, Bergeron J, Lamarche B, Despres JP. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abnormal obesity. J Lipid Res. 2001;42:2007-14.
23. Esrey KL, Joseph L, Grover SA. Relationship between dietary intake and coronary heart disease mortality: lipid research clinics prevalence follow-up study. J Clin Epidemiol. 1996;49:211-6.
24. McNamara DJ. Dietary cholesterol and atherosclerosis. Biochim Biophys Acta. 2000;1529:310-20.
25. Kritchevsky SB. A review of scientific research and recommendations regarding eggs. J Am Coll Nutr. 2004;23:596S-600S.
26. Krumholz HM, Seeman TE, Merrill SS, Mendes de Leon CF, Vaccarino V, Silverman DI, Tsukahara R, Ostfeld AM, Berkman LF. Lack of association between cholesterol and coronary heart disease mortality and morbidity and allcause mortality in persons older than 70 years. JAMA. 1994;272:1335-40.
27. Nakamura Y, Iso H, Kita Y, Heshina H, Okada I, Konishi M, Inoue M, Tsugane S. Egg consumption, serum total cholesterol concentrations and coronary heart disease incidence: Japan Public Health Centerbased prospective study. Br J Nutr. 2006;96:921-8.
28. Qureshi AI, Suri FK, Ahmed S, Nasar A, Divani AA, Kimani JF. Regular egg consumption does not increase the risk of stroke and cardiovascular diseases. Med Sci Monit. 2007;13:CR1-8.
29. Osei-Hwedieh DO, Amar M, Sviridov D, Remaley AT. Apolipoprotein mimetic peptides: mechanisms of action as anti-atherogenic agents. Pharmacol Ther. 2011;130:83-91.
30. Fryirs MA, Barter PJ, Appavoo M, Tuch BE, Tabet F, Heather AK, Rye KA. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arterioscler Thromb Vasc Biol. 2010;30:1642-8.
31. Drew BG, Duffy SJ, Formosa MF, Natoli AK, Henstridge DC, Penfold SA, Thomas WG, Mukhamedova N, de Courten B, Forbes JM, et al. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation. 2009;119:2103-11.
32. Patel S, Di Bartolo BA, Nakhla S, Heather AK, Mitchell TW, Jessup W, Celermajer DS, Barter PJ, Rye KA. Anti-inflammatory effects of apolipoprotein A-I in the rabbit. Atherosclerosis. 2010;212:392-7.
33. Tabet F, Rye KA. High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond). 2009;116:87-98.
34. Drew BG, Fidge NH, Gallon-Beaumier G, Kemp BE, Kingwell BA. High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci U S A. 2004;101:6999-7004.
35. Forte TM, Oda MN, Knoff L, Frei B, Suh J, Harmony JA, Stuart WD, Rubin EM, Ng DS. Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration. J Lipid Res. 1999;40:1276-83.
36. Nofer JR, Brodde MF, Kehrel BE. High-density lipoproteins, platelets and the pathogenesis of atherosclerosis. Clin Exp Pharmacol Physiol. 2010;37:726-35.
37. Jahangiri A. High-density lipoprotein and the acute phase response. Curr Opin Endocrinol Diabetes Obes. 2010;17:156-60.
38. Ng KM, Lee YK, Lai WH, Chan YC, Fung ML, Tse HF, Siu CW. Exogenous expression of human apoA-I enhances cardiac differentiation of pluripotent stem cells. PLoS ONE. 2011;6:e19787.
39. Sumi M, Sata M, Miura S, Rye KA, Toya N, Kanaoka Y, Yanaga K, Ohki T, Saku K, Nagai R. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemiainduced angiogenesis. Arterioscler Thromb Vasc Biol. 2007;27:813-8.
40. Mineo C, Yuhanna IS, Quon MJ, Shaul PW. High density lipoproteininduced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J Biol Chem. 2003;278:9142-9.
41. Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med. 2011;364:127-35.
42. Fazio S, Linton MF. Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogma. J Clin Endocrinol Metab. 2009;94:1081-3.
43. Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Zuurman MW, van der Steege G, van Tol A, Dullaart RP. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study. J Clin Endocrinol Metab. 2006; 91:3382-8.
44. Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation. 2003;108:2054-9.
45. Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Ogawa H. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol. 2009;54:601-8.
46. Katz DL, Evans MA, Nawaz H, Njike VY, Chan W, Comerford BP, Hoxley ML. Egg consumption and endothelial function: a randomized controlled crossover trial. Int J Cardiol. 2005;99:65-70.
47. Njike V, Faridi Z, Dutta S, Gonzalez-Simon AL, Katz DL. Daily egg consumption in hyperlipidemic adults-effects on endothelial function and cardiovascular risk. Nutr J. 2010;9:28.
48. National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). NIH Pub. No. 02-5215. Bethesda, MD: National Heart, Lung, Blood Institute;2002.
49. Klein CJ, editor. The scientific evidence and approach taken to establish guidelines for cholesterol intake in Australia, Canada, the United Kingdom, and the United States. Bethesda, MD: Life Sciences Research Office, Inc.;2006. Available from: http://www.nhlbi.nih.gov/guidelines/ cholesterol/index.htm.
50. Fernandez ML. Letter to the editor: eggs and health benefits. Can J Cardiol. 2011;27:264 e1.
51. Dietary Guidelines Advisory Committee Report, 2010. Available from: http://www.dietaryguidelines.gov/
52. Fernandez ML. Effects of eggs on plasma lipoproteins in healthy populations. Food Function. 2010;1:156-60.